Choong Ang Vaccine Laboratory Co. Ltd (KQ:072020) — Market Cap & Net Worth
Market Cap & Net Worth: Choong Ang Vaccine Laboratory Co. Ltd (072020)
Choong Ang Vaccine Laboratory Co. Ltd (KQ:072020) has a market capitalization of $57.71 Million (₩85.16 Billion) as of September 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #21465 globally and #1259 in its home market, demonstrating a -0.33% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Choong Ang Vaccine Laboratory Co. Ltd's stock price ₩9200.00 by its total outstanding shares 9256781 (9.26 Million). Also see total assets of Choong Ang Vaccine Laboratory Co. Ltd for a full breakdown of the balance sheet.
Choong Ang Vaccine Laboratory Co. Ltd Market Cap History: 2015 to 2026
Choong Ang Vaccine Laboratory Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $78.25 Million to $57.71 Million (-3.13% CAGR). Also see Choong Ang Vaccine Laboratory Co. Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Choong Ang Vaccine Laboratory Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$235.78 Billion | 0.02% | #578 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$235.78 Billion | 0.02% | #578 of 1384 |
Weight: Choong Ang Vaccine Laboratory Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Choong Ang Vaccine Laboratory Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Choong Ang Vaccine Laboratory Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 072020 live share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Choong Ang Vaccine Laboratory Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
Choong Ang Vaccine Laboratory Co. Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $119.22 Million | $37.90 Billion | $6.21 Billion | 0.00x | 0.02x |
| 2017 | $84.04 Million | $31.87 Billion | $4.58 Billion | 0.00x | 0.02x |
| 2018 | $100.88 Million | $33.15 Billion | $3.45 Billion | 0.00x | 0.03x |
| 2019 | $109.70 Million | $32.90 Billion | $1.85 Billion | 0.00x | 0.06x |
| 2020 | $105.26 Million | $36.32 Billion | $3.16 Billion | 0.00x | 0.03x |
| 2021 | $92.40 Million | $40.91 Billion | $7.60 Billion | 0.00x | 0.01x |
| 2022 | $68.38 Million | $39.30 Billion | $4.04 Billion | 0.00x | 0.02x |
| 2023 | $69.07 Million | $41.87 Billion | $6.00 Billion | 0.00x | 0.01x |
| 2024 | $61.48 Million | $45.59 Billion | $6.85 Billion | 0.00x | 0.01x |
| 2025 | $61.48 Million | $49.07 Billion | $6.16 Billion | 0.00x | 0.01x |
Competitor Companies of 072020 by Market Capitalization
Companies near Choong Ang Vaccine Laboratory Co. Ltd in the global market cap rankings as of September 19, 2026. Review Choong Ang Vaccine Laboratory Co. Ltd tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Choong Ang Vaccine Laboratory Co. Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #613 globally with a market cap of $44.92 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #670 globally with a market cap of $40.99 Billion USD ( CN¥280.10 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #613 | GALDERMA GROUP AG | NYSE:GALDY | $44.92 Billion | $38.53 |
| #635 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.90 |
| #670 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $40.99 Billion | CN¥43.91 |
Choong Ang Vaccine Laboratory Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Choong Ang Vaccine Laboratory Co. Ltd's market cap moved from $78.25 Million to $ 57.71 Million, with a yearly change of -3.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩57.71 Million | -6.12% |
| 2025 | ₩61.48 Million | 0.00% |
| 2024 | ₩61.48 Million | -10.99% |
| 2023 | ₩69.07 Million | +1.01% |
| 2022 | ₩68.38 Million | -26.00% |
| 2021 | ₩92.40 Million | -12.22% |
| 2020 | ₩105.26 Million | -4.05% |
| 2019 | ₩109.70 Million | +8.74% |
| 2018 | ₩100.88 Million | +20.03% |
| 2017 | ₩84.04 Million | -29.50% |
| 2016 | ₩119.22 Million | +52.35% |
| 2015 | ₩78.25 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Choong Ang Vaccine Laboratory Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $57.71 Million USD |
| MoneyControl | $57.71 Million USD |
| MarketWatch | $57.71 Million USD |
| marketcap.company | $57.71 Million USD |
| Reuters | $57.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Choong Ang Vaccine Laboratory Co. Ltd
Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Ko… Read more